To the full analysis
Repligen stock: growth
RGENRepligen reported $738.26M in revenue for fiscal 2025, up 16.4% on the prior year, up 15% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
23.7%
per year from 2005 to 2025, per share 19.7%
Earnings (Annual rate)
25.1%
per year from 2005 to 2025, per share 21%
Free cash flow (Annual rate)
no data
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2015 | since 2005 | |
|---|---|---|---|
| Revenue | 15.0% | 24.3% | 23.7% |
| Revenue per share | 13.5% | 17.8% | 19.7% |
| Earnings | −4.0% | 18.0% | 25.1% |
| Earnings per share | −5.3% | 12.0% | 21.0% |
| Free cash flow | 20.9% | 22.4% | no data |
| Free cash flow per share | 19.3% | 16.0% | no data |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2005 | $12.91M | $696.86K | −$320.11K |
| 2006 | $14.07M | −$889.26K | −$921.05K |
| 2007 | $19.3M | $37.11M | $37.36M |
| 2008 | $29.36M | $5.75M | $4.97M |
| 2009 | $20.97M | −$4.06M | −$3.05M |
| 2010 | $27.29M | −$43.51K | $2.71M |
| 2012 | $62.27M | $14.16M | $12.18M |
| 2013 | $68.17M | $16.09M | $21.3M |
| 2014 | $63.55M | $8.17M | $12.8M |
| 2015 | $83.54M | $9.35M | $12.43M |
| 2016 | $104.54M | $11.68M | $3.2M |
| 2017 | $141.24M | $28.35M | $12M |
| 2018 | $194.03M | $16.62M | $18.73M |
| 2019 | $270.25M | $21.41M | $44.06M |
| 2020 | $366.26M | $59.93M | $36.28M |
| 2021 | $670.53M | $128.29M | $51.93M |
| 2022 | $801.54M | $185.96M | $38.74M |
| 2023 | $632.36M | $35.6M | $74.93M |
| 2024 | $634.44M | −$25.51M | $142.49M |
| 2025 | $738.26M | $48.89M | $93.9M |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 29 Oct 2026)
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.